Prior Stephen David 4
4 · AN2 Therapeutics, Inc. · Filed Feb 28, 2025
Insider Transaction Report
Form 4
Prior Stephen David
Chief Strategy Officer
Transactions
- Award
Common Stock
2025-02-26+28,000→ 61,313 total - Award
Stock Option (right to buy)
2025-02-26+56,000→ 56,000 totalExercise: $1.13Exp: 2035-02-25→ Common Stock (56,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2025, subject to the Reporting Person's continuous service as of such date.
- [F2]Includes (a) 10,125 RSUs which shall vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024 and (b) 12,031 RSUs which shall vest on January 1, 2026, in each case, subject to the Reporting Person continuing to provide services to the Company as an employee, consultant or director of the Company through each applicable vesting date.
- [F3]The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2025, subject to the Reporting Person's continuous service as of such date.